Baseline eGFR cutoff for increased risk of post-contrast acute kidney injury in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction in the emergency department

PLoS One. 2023 Oct 26;18(10):e0293598. doi: 10.1371/journal.pone.0293598. eCollection 2023.

Abstract

Acute myocardial infarction is an acute-stage disease that requires prompt diagnosis and treatment. Primary percutaneous coronary intervention (pPCI) for ST-elevation myocardial infarction (STEMI) is a high-risk factor for post-contrast acute kidney injury (PC-AKI). This retrospective cohort study analyzed the data of 754 patients with STEMI who underwent pPCI and were integrated into the Fast Interrogation Rule for STEMI critical pathway program between 2015 and 2019. We aimed to determine the optimal cutoff baseline eGFR for identifying a high risk of PC-AKI after multivariable adjustment with statistically significant risk factors. We also compared the incidence rates of PC-AKI between the previous and current diagnostic criteria. The probability of PC-AKI increased when the baseline estimated glomerular filtration rate (eGFR) was ≤ 79mL/min/1.73 m2. The optimal cutoff baseline eGFR for high risk of PC-AKI was found to be an eGFR of ≤ 61 mL/min/1.73 m2 after multivariable adjustment. The current diagnostic criteria more accurately identified the patient group with impaired renal function. Our results have clinically significant implications for identifying patients at a high risk of developing PC-AKI, especially before and after the use of contrast agents in patients who require PCI for STEMI in the emergency department.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury* / diagnosis
  • Acute Kidney Injury* / epidemiology
  • Acute Kidney Injury* / etiology
  • Contrast Media / adverse effects
  • Emergency Service, Hospital
  • Glomerular Filtration Rate
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Percutaneous Coronary Intervention* / methods
  • Retrospective Studies
  • Risk Factors
  • ST Elevation Myocardial Infarction*

Substances

  • Contrast Media

Grants and funding

Funding: This study was supported by a grant from the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT & Future Planning (NRF - 2019R1C1C1006332 to J.H.B., and NRF - 2021R1C1C1009209 to J.S.Y.) and a faculty research grant from Yonsei University College of Medicine for 6-2020-0086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.